MediXall Group, Inc. announced earnings results for the third quarter ended September 30, 2020. For the third quarter, the company announced sales was USD 0 compared to USD 807 a year ago. Net loss was USD 966,631 compared to USD 714,878 a year ago. Basic loss per share from continuing operations was USD 0.01 compared to USD 0.01 a year ago. For the nine months, sales was USD 0 compared to USD 2,253 a year ago. Net loss was USD 3.963 million compared to USD 2.129 million a year ago. Basic loss per share from continuing operations was USD 0.04 compared to USD 0.03 a year ago.